Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENDRA Life Sciences Inc

6.13
-0.8700-12.43%
Post-market: 6.130.00000.00%19:56 EDT
Volume:97.92K
Turnover:637.75K
Market Cap:4.61M
PE:-0.36
High:7.17
Open:6.73
Low:6.13
Close:7.00
52wk High:22.68
52wk Low:2.90
Shares:752.80K
Float Shares:752.70K
Volume Ratio:0.03
T/O Rate:13.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.0082
EPS(LYR):-56.9402
ROE:-167.48%
ROA:-80.91%
PB:3.13
PE(LYR):-0.11

Loading ...

ENDRA Life Sciences Inc. Announces Date for Upcoming Annual Stockholder Meeting

Reuters
·
Yesterday

ENDRA Life Sciences Issues Correction to October 15, 2025, SEC Filing to Address Technical Submission Error

Reuters
·
Oct 16

ENDRA Life Sciences Announces $14.4 Million Private Placement to Launch Digital Asset Treasury Strategy Managed by Arca

Reuters
·
Oct 15

Top Premarket Decliners

MT Newswires Live
·
Oct 14

BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv

Reuters
·
Oct 14

ENDRA Life Sciences Announces $4.9 Million Private Placement to Launch Digital Asset Treasury Strategy Managed by Arca

Reuters
·
Oct 13

ENDRA Life Sciences Announces at-Market Private Placement of up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager ARCA

THOMSON REUTERS
·
Oct 13

ENDRA Life Sciences Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Sep 22

U.S. RESEARCH ROUNDUP-Apple, GE Aerospace, Tesla

Reuters
·
Sep 22

ENDRA Life Sciences Q2 EPS $(1.71) Beats $(2.27) Estimate

Benzinga
·
Aug 15

ENDRA Life Sciences Reports Q2 2025 Net Loss of $1.2M, Down from $2.2M Year-Over-Year; Operating Expenses Decrease by 42%

Reuters
·
Aug 15

ENDRA Life Sciences Q2 Operating Expenses USD 1.2 Million

THOMSON REUTERS
·
Aug 15

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

GlobeNewswire
·
Aug 14

BRIEF-ENDRA Life Sciences Authorizes Cryptocurrency Treasury Strategy

Reuters
·
Jul 23

ENDRA Life Sciences Inc - Authorizes Cryptocurrency Treasury Strategy - SEC Filing

THOMSON REUTERS
·
Jul 23

ENDRA Life Sciences Inc. Appoints Cryptocurrency Advisory Board to Guide New Treasury Strategy

Reuters
·
Jul 23

ENDRA Life Sciences Reports No Revenue for Q2 2025, Narrows Net Loss to $1.3 Million

Reuters
·
Jul 10

ENDRA Life Sciences Files Preliminary Prospectus for Share, Warrant Offering

MT Newswires Live
·
Jul 09

Top Premarket Gainers

MT Newswires Live
·
Jul 08

ENDRA Life Sciences Unveils Multisite Clinical Study to Enhance TAEUS Liver Device Accuracy Ahead of FDA Pivotal Trial

Reuters
·
Jun 16